Product Details for ANDA 210611
OXYBUTYNIN CHLORIDE (OXYBUTYNIN CHLORIDE) 5MG
Marketing Status: Prescription
Active Ingredient: OXYBUTYNIN CHLORIDE
Proprietary Name: OXYBUTYNIN CHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 5MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A210611
Product Number: 001
Approval Date: Oct 30, 2019
Applicant Holder Full Name: NOVAST LABORATORIES LTD
Marketing Status: Prescription
Patent and Exclusivity Information
目前南通联亚药业在美国市场获批上市的品种多达数十个，其中多个为缓控释产品。
